Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online materials
About the toc
1 September 2012 vol. 83 no. 9 894-902J Neurol Neurosurg Psychiatry
- Supplementary Data
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.